Skip to content
Search

Donate

Donate

Bringing Cancer Clinical Trials Closer to Home

This article first appeared in the 2025 Annual Update >

Clinical trials can offer cancer patients access to advanced treatments before they become widely available. At Shaw Cancer Center, 21 active clinical trials provide patients in our community options they would otherwise need to travel hours to access at larger academic medical centers in Denver or beyond.

As the clinical research program at Shaw expands, two key technologies—the Velos Clinical Trial Management System (CTMS) and the Florence Regulatory System—now help Shaw manage trials more safely, efficiently, and in compliance with regulatory requirements.

Tools Behind the Trials

Clinical trials involve complex data, documentation, timelines, and compliance requirements. The Velos CTMS centralizes participant information, tracks research progress, and supports regulatory alignment, reducing the risk of error and improving data quality.

The Florence Regulatory System is equally critical, as it digitizes regulatory documentation to reduce manual work, improves organization, and keeps Shaw’s research team audit-ready and aligned with current standards. Together, these systems support compliance, efficiency, and the growing complexity of modern clinical research.

“The Velos CTMS and Florence Regulatory System directly support our ability to conduct effective and compliant clinical trials, facilitating the continued growth of our research program,” said Paige Bordelon, Clinical Research Supervisor at Shaw.

Strengthening Access and Capacity

These systems enable Shaw to manage more trials, collaborate more effectively with research partners, and maintain the rigorous standards required for clinical research. For patients, this expanded capacity means that more treatment options are available locally, allowing them to avoid the physical, emotional, and financial burden of traveling long distances during an already difficult time.

Philanthropic support from benefactors who believe cancer research and care should remain accessible to our community enabled Shaw’s adoption of both systems.

Share This